Cancer Cell

Cancer Cell provides a high-profile forum for showcasing advances in cancer research, with a strong emphasis on translational research.

[Cancer Cell @Cancer_Cell]

Check out our August issue, fresh off the press: https://t.co/ybIhO6JwDW

[Cancer Cell @Cancer_Cell]

Scherer’s map, remapped https://t.co/HA2WsTxQXs

[Cancer Cell @Cancer_Cell]

Spatial analysis reveals the evolving organization of IDH-mutant glioma https://t.co/AX6uc6ZCm8

[Cancer Cell @Cancer_Cell]

TIME in motion: How response takes shape https://t.co/WMrbMPhNxr

[Cancer Cell @Cancer_Cell]

Tumor evolution shapes metastatic competence in colorectal cancer https://t.co/wAV2I4w6SE

[Cancer Cell @Cancer_Cell]

Looking forward to our session on "Systems oncology" @CellPressEvents Hallmarks of cancer, with speakers @leeat_keren, Zemin Zhang @CQMU1956, & @TiroshLab.
Register today and secure your place: https://t.co/1QZnsYtjve
#CSHallmarks2026

[Cancer Cell @Cancer_Cell]

Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer https://t.co/SqdvXfzpUs

[Cancer Cell @Cancer_Cell]

Tumor immune microenvironment remodeling predicts response to checkpoint inhibitor therapy https://t.co/y68GcZDwfM

[Cancer Cell @Cancer_Cell]

Axes of biological variation in diffuse large B cell lymphoma https://t.co/VEXzQhHW4b

[Cancer Cell @Cancer_Cell]

MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism https://t.co/Nk5FSgV7Fr

[Cancer Cell @Cancer_Cell]

Biological aging and the hidden architecture of early-onset cancer risk https://t.co/jjGF8gzvvv

[Cancer Cell @Cancer_Cell]

Tumor-infiltrating plasma cell targets as a source for immunotherapies https://t.co/q6LsE1vRSc

[Cancer Cell @Cancer_Cell]

Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies https://t.co/NqFNa5UUFz

[Cancer Cell @Cancer_Cell]

A self-amplifying nerve-fibroblast circuit drives colorectal cancer progression https://t.co/9msuIzcluV

[Cancer Cell @Cancer_Cell]

EGFR-targeting ADCs: From oncogene addiction to antigen-guided drug delivery https://t.co/GgYGolGIFk

[Cancer Cell @Cancer_Cell]

SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial https://t.co/gfl4J0BzIp

[Cancer Cell @Cancer_Cell]

Retraction Notice to: Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity https://t.co/SnBVpq40hF

[Cancer Cell @Cancer_Cell]

Latent tumor killers awakened https://t.co/vPyoGx0ZBZ

[Cancer Cell @Cancer_Cell]

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment https://t.co/wzxSeYauDC

[Cancer Cell @Cancer_Cell]

A stress-adaptive lipid kinase axis defines metabolic vulnerabilities in neuroendocrine prostate cancer https://t.co/5bQnDMCHUl

[Cancer Cell @Cancer_Cell]

Depletion of an immature cord blood NK subset reverses trogocytosis-driven CAR NK dysfunction https://t.co/Qh1uAGEvlc